<DOC>
	<DOCNO>NCT01757665</DOCNO>
	<brief_summary>The objective trial confirm modification tissue processing , valve sterilization packaging raise new question safety effectiveness subject require replacement native prosthetic aortic mitral valve .</brief_summary>
	<brief_title>ProspeCtive , nOn-randoMized , MulticENter Clinical Evaluation Edwards Pericardial Bioprostheses With New Tissue Treatment Platform ( COMMENCE )</brief_title>
	<detailed_description>Multicenter , prospective , single arm trial - Up seven hundred ( 700 ) aortic valve replacement ( AVR ) subject one hundred seventy-five ( 175 ) mitral valve replacement ( MVR ) subject forty ( 40 ) clinical site enrol . The trial include male female patient , 18 year old , require replacement diseased , damage , malfunction native prosthetic aortic mitral valve . Patients follow assessed implant 5 year .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Stenosis</mesh_term>
	<criteria>Eligibility Criteria : 1 . Is 18 year old 2 . Provides write informed consent prior trial procedure 3 . Agrees attend followup assessment 5 year willing comply specify followup evaluation clinical investigational site participate COMMENCE trial and/or obtain protocolspecified diagnostic test center IRB healthcare system 4 . Diagnosed aortic mitral valve disease require valve replacement base pre operative evaluation 5 . Scheduled undergo plan aortic mitral valve replacement without concomitant bypass surgery 6 . Scheduled undergo plan aortic valve replacement without resection replacement ascend aorta sinotubular junction without need circulatory arrest hemi arch arch replacement Exclusion criterion : A subject meeting follow criterion shall exclude : 1 . Requires emergency surgery 2 . Requires plan multiple valve replacement/ repair ( exception mitral valve replacement tricuspid valve repair ) 3 . Has prior valve surgery , include implant bioprosthetic valve , mechanical valve , annuloplasty ring remain situ 4 . Requires surgical procedure outside cardiac area ( e.g . vascular bypass ) 5 . Requires surgical replacement aortic root 6 . Has active endocarditis/myocarditis endocarditis/myocarditis within 3 month schedule aortic mitral valve replacement surgery 7 . Has renal insufficiency determine creatinine ( SCr ) level ≥ 2.5 mg/dL end stage renal disease require chronic dialysis screen visit 8 . Has MRI CT scan confirm stroke , cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) within 6 month ( 180 day ) prior plan valve surgery 9 . Has acute myocardial infarction ( MI ) within 30 day prior plan valve surgery 10 . Has presence noncardiac disease limit life expectancy le 12 month 11 . Diagnosed hypertrophic obstructive cardiomyopathy ( HOCM ) 12 . Diagnosed abnormal calcium metabolism hyperparathyroidism 13 . Exhibits leave ventricular ejection fraction ≤ 20 % validate diagnostic procedure prior plan valve surgery 14 . Echocardiographic evidence intracardiac mass , thrombus , vegetation 15 . Hemodynamic respiratory instability require inotropic support , mechanical circulatory support , mechanical ventilation within 30 day prior plan valve surgery 16 . Documented leukopenia ( WBC &lt; 3.5x 10³/μL ) , acute anemia ( Hgb &lt; 10.0 gm/dL 6 mmol/L ) thrombocytopenia ( platelet count &lt; 50x 10³/μL ) accompany history bleed diathesis coagulopathy 17 . Has prior organ transplant currently organ transplant candidate 18 . Current recent participation ( within 6 week prior surgery ) another drug device trial 19 . Was previously implant trial device ( Model 11000A Model 11000M ) 20 . Pregnant ( female subject childbearing potential ) , lactate plan become pregnant duration participation trial 21 . Currently incarcerate unable give voluntary inform consent 22 . Documented history substance ( drug alcohol ) abuse within last 5 year prior implant 23 . Requires concomitant leave ventricular assist device ( LVAD ) placement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Aortic valve replacement</keyword>
	<keyword>Mitral valve replacement</keyword>
</DOC>